Structural brain abnormalities detected by MRI are among the risk factors the funded researchers will identify as novel biomarkers.

More than 40% of Americans are generally OK with the thought of AI reading their chest x-rays. Moreover, some 12.3% are very comfortable with the prospect.

U.S. healthcare is now a solid week into the CT contrast shortage of ’22, and common themes are emerging in adaptations at local hospitals and imaging centers.

In some cases hospital staff kept no watch over outside-looking-in connections between manufacturers and scanners.

The FDA has OK’d the use of MR imaging for patients implanted with an autonomic heart-stimulation device as long as the device’s labeled guidelines are followed at the imaging site.

Lisa Mead, PSO executive director, Strategic Radiology, spoke at the Radiology Business Management Association (RBMA) 2022 meeting on her organization's experience collaborating with a large number of radiology groups.

Along with radiology-specific software and products, the list may include newly greenlit offerings for use in other settings that are increasingly important to multidisciplinary care.

The FDA has approved a lab test for evaluating cognitively impaired adults who may be in the early stages of Alzheimer’s disease.